Facebook
Twitter
YouTube
RSS
JOIN OUR MAILING LIST
Search
Home
About
About The Foundation
Our Founder
Mission Statement
Board Members
CCF Staff
Financial Disclosure
Donations to CCF
For Patients
Diagnosis
Newly Diagnosed
Newly Diagnosed #2
Diagnosis and Follow Up Tests
Checklist for the Newly Diagnosed
Treatment
Treatment Options
Find A Doctor
Clinical Trials
General Information
Living With Carcinoid
Nutrition
Nutritional Concerns For The Carcinoid Patient
Nutrition and Diet for Carcinoid Patients
Tips and Resources
What If Insurance Won’t Pay?
Resources for Carcinoid and NET Cancer Insurance Appeals
Mobile App
A Review of Neuroendocrine Cancer
UN ANÁLISIS DEL CÁNCER NEUROENDOCRINO
Medical Opinion: Diagnosis and Treatment
Medical Opinion: When to Start and How to Treat Metastatic Carcinoid
More Information
Frequently Asked Questions
Ask the NET Expert
Medical Glossary
In-Depth Information
Website Suggestions
Videos
CCF 2022 Video Series
CCF 2020 Video Series
CCF 50th Anniversary Videos
CCF 2012 Video Series
ACOR Carcinoid E-Group Archives
Living With Neuroendocrine Tumors
Resources
Support Groups
Directory
Online Support and Discussion Groups
Starting a Support Group
Survival
Survivor Stories
Submit Your Story
Events
FAQ
Additional Resources
Awareness Items
Lodging and Travel
Financial Assistance
News
Blog
E-News Archives
Contact
Donate
Carcinoid Cancer Foundation
Carcinoid Syndrome, Lexicon Pharmaceuticals, Telotristat Etiprate Clinical Trial
August 4, 2015
Our Twitter Feed
Tweets by @CarcinoidNETs
